We are pleased to invite investors and analysts to participate in a live webinar on Wednesday, 17 November 2021, highlighting Roche’s development in digital technology, data and advanced analytics. 16:00 - 17:30 CET / 15:00 - 16:30 GMT 10:00 - 11:30 am EST / 07:00 - 08:30 am PST The webinar will be hosted by Alan Hippe, Chief Financial and IT Officer, and other senior leaders in the space followed by a Q&A session. The event will outline the overall strategy and highlight >20 use cases (including launched products) from the pharmaceuticals & diagnostics divisions. Use cases presented will cover the entire traditional value chain (early R&D, clinical development, regulatory & reimbursement, manufacturing, commercialization, diagnosis) as well as novel treatment/decision support solutions for physicians and patients. Presenters include:
The slides will be available for download at 15:00 CET on the day of the event. > click here We would like to invite all interested parties to participate in the webinar and to pre-register here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com *privacy notice | ||
Best regards, Karl Mahler Head of Investor Relations | Bruno Eschli Investor Relations Officer | Gerard Tobin Investor Relations Officer |
Roche Investor Relations | ||
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com | Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com | |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com | Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com | |
Investor Relations North America | ||
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.